Navigation For Mobile
  1. >
  2. Blog
  3. >
  4. Neuland Labs
  5. >
  6. Reflections on DCAT Week 2017 &...

Reflections on DCAT Week 2017 & AsiaTIDES, Japan

This year’s DCAT Week saw a new format and setting, while Neuland’s first AsiaTIDES show demonstrated the growing importance of peptides to the Japanese & Asian pharma industries. Here are brief recaps of these two global shows:

DCAT 2017
We have historically been a sponsor at DCAT Week, and this year was no exception. We did expand our sponsorship activities this year to include the DCAT mobile app. This proved an excellent choice, given that DCAT changed venues this year for the first time in its history. With events spread out across New York City, the app enabled participants to navigate different events & suites and schedule meetings, while also learning more about Neuland and its various contract pharma products & services.

This year’s DCAT show began on a Monday, as opposed to previous years in which it was a mid-week show. It was one of many changes – notably, the venue shift from the venerable Waldorf Astoria to the Hotel Continental Barclay. From our standpoint, it actually worked out for the better. There just generally seemed to be more cross-pollination of people from other hotels – leading to better attendance at various events – including our own.

A little more than two-thirds of our meetings across the three days were focused on Neuland’s Generic Drug Substances (GDS) business.

AsiaTIDES
AsiaTIDES – held earlier this year in Kyoto, Japan’s oldest city (and former capital city) – is a conference focused exclusively on peptides and oligonucleotides (hence the ‘tides’). The last ten years has seen growing research, deal-making and clinical activity in peptide and oligo therapeutic programs, and AsiaTIDES represents one of the key events focused on oligonucleotide and peptide research and commercialization.

At the show, our team did an excellent job promoting Neuland’s advanced capabilities in the peptide space. Neuland – with expertise in both solution phase and solid phase synthesis methodologies – offers a full range of peptide synthesis services. These include the production of peptides from milligrams to multi-kilogram scale by standard sequential chemical peptide syntheses and segment condensation strategies.

Among the services our team discussed with attendees were our proprietary Prep-HPLC technique to increase throughput during peptide purification 10-20 fold, our large-scale manufacturing capabilities for complex amino acids & Fmoc-building blocks, and our peptide regulatory support services.

It was a well-attended show, which speaks highly of the therapeutic potential for the growing ‘-tides industry.

Thanks to all of our team members who helped make both shows a success!

 

Comments are closed.